United States: Biosimilar Deals Updates: Biocon, AstraZeneca - Goodwin Procter LLP

Mondaq

05 Jan 2024 0 shares 1 views

United States: Biosimilar Deals Updates: Biocon, AstraZeneca - Goodwin Procter LLP

Mondaq

Published 05 Jan 2024

As an update to our previous report, Biocon Biologics Ltd. (a subsidiary of Biocon Ltd.) announced the successful completion of the transition of the acquired biosimilars...

Full Article

United States: Breaking: Judgment In Regeneron v. Mylan (Aflibercept) BPCIA Case Finding Some Claims Of Asserted Patents Valid And Infringed - Goodwin Procter LLP

As previously reported by Big Molecule Watch, trial in Regeneron's BPCIA case against Biocon regarding Biocon's proposed..

Mondaq 08 Jan 2024

United States: Updates On Patent Challenges By Biosimilar Manufacturers At The PTAB - Goodwin Procter LLP

In the last month, there has been a flurry of activity at the PTAB related to challenges from biosimilar manufacturers related to..

Mondaq 03 Jan 2024

United States: Biosimilar Deals Updates: Biocon, AstraZeneca - Goodwin Procter LLP

United States: Biosimilar Deals Updates: Biocon, AstraZeneca - Goodwin Procter LLP

You might like

Related news coverage

United States: Breaking: Judgment In Regeneron v. Mylan (Aflibercept) BPCIA Case Finding Some Claims Of Asserted Patents Valid And Infringed - Goodwin Procter LLP

United States: Updates On Patent Challenges By Biosimilar Manufacturers At The PTAB - Goodwin Procter LLP

Advertisement